Patients with Crohn’s disease who start on infliximab combined with an immunomodulator have far better outcomes within a year compared with traditional ‘step-up’ treatment, a…
Patients with higher levels of intra-abdominal visceral fat are less likely to achieve improvements from biologic treatments for inflammatory bowel disease, a US study shows.…
Early ileocecal resection could be an effective first-line therapy for Crohn’s disease, according to Danish and US gastroenterologists, challenging the current paradigm of reserving surgery…
Patients with refractory immune checkpoint inhibitor-induced colitis may benefit from faecal microbiota transplants, according to a study in Science Translational Medicine. Doctors from the University…
Patients with depression are more than twice as likely to be diagnosed with inflammatory bowel disease compared with those without depression, according to a systematic…
Achieving and maintaining remission of inflammatory bowel disease should be prioritised in women before conceiving and during pregnancy, according to new guidance. Methotrexate, allopurinol and…
Half of patients with ulcerative colitis lose their remission response to tofacitinib after dose de-escalation, which is only “partially recaptured” with increasing maintenance dose, real-world…
Sticking to a healthy lifestyle may substantially decrease the burden of Crohn’s disease and ulcerative colitis, with US research showing about one in two cases…
Routine monitoring no better than conventional management with anti-TNF therapy, researchers show.
However, in two subgroups live birth rates are lower than for the general population, researchers say.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
